Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate 13107-0071
Product NDC
13107-0071- Manufacturer
- Aurolife Pharma, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- November 27, 2013
- Listing Expires
- December 31, 2026
- Application
- ANDA202424
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 3.125 mg/1 |
| Amphetamine Sulfate | 3.125 mg/1 |
| Dextroamphetamine Saccharate | 3.125 mg/1 |
| Dextroamphetamine Sulfate | 3.125 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Packaging Options(5)
100 TABLET in 1 BOTTLE (13107-071-01)
500 TABLET in 1 BOTTLE (13107-071-05)
250 TABLET in 1 BOTTLE (13107-071-25)
50 TABLET in 1 BOTTLE (13107-071-50)
1000 TABLET in 1 BOTTLE (13107-071-99)